ctrl K

Price Alert

Kazia Therapeutics Limite... (KZIA)

NASDAQ: KZIA · Real-Time Price · USD

7.90

-0.37 (-4.47%)

At close: Aug 15, 2025, 3:59 PM

8.04

1.71%

After-hours: Aug 15, 2025, 04:10 PM EDT

Kazia Therapeutics Balance Sheet Statement

Financials in AUD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	1.66M	5.24M	7.36M	27.59M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	40K	42.92K	7.3M	-22M
Receivables	133K	610.00	51K	76K
Inventory	n/a	-3.79M	n/a	-84K
Other Current Assets	n/a	3.9M	n/a	8.36K
Total Current Assets	6.14M	10.77M	7.61M	29.39M
Property-Plant & Equipment	n/a	n/a	n/a	n/a
Goodwill & Intangibles	15.4M	17.27M	20.05M	22M
Total Long-Term Assets	15.44M	17.31M	27.35M	22M
Total Assets	21.59M	28.09M	34.96M	58.09M
Account Payables	4.55M	857K	1.52M	1.89M
Deferred Revenue	n/a	n/a	-1.84M	n/a
Short-Term Debt	634K	1.8M	1.84M	n/a
Other Current Liabilities	10.1M	750.25K	-914.84K	791K
Total Current Liabilities	25.8M	7.57M	4.69M	8.33M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3.79M	8.47M	9.07M	8.98M
Total Long-Term Liabilities	5.8M	8.47M	11.64M	13.29M
Total Liabilities	31.6M	16.03M	16.32M	20.24M
Total Debt	634K	1.8M	1.84M	n/a
Common Stock	101.64M	97.45M	84.48M	80.29M
Retained Earnings	-115.13M	-89.08M	-68.25M	-44.2M
Comprehensive Income	3.48M	3.68M	2.41M	1.3M
Shareholders Equity	-10.02M	12.05M	18.64M	37.85M
Total Investments	n/a	n/a	n/a	n/a